News from oncosec medical inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 23, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec to Webcast Annual Meeting of Stockholders

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, invites investors and...

Jul 14, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical to Participate in Webcast on Advances in Cancer Immunotherapy

OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that Robert H....

Jul 06, 2015, 06:00 ET
OncoSec Medical, Inc. Logo

OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the...

Jul 01, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell

OncoSec Medical Inc. ("OncoSec") (Nasdaq: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that CEO and...

Jun 25, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Appoints Richard B. Slansky as Chief Financial Officer

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the...

Jun 17, 2015, 16:50 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Issues Annual Letter To Shareholders

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today issued the...

Jun 16, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information

OncoSec Medical Enrolls First Patient in Squamous Cell Carcinoma of the Head and Neck Phase II Clinical Trial

OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the...

Jun 15, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Set to Join Russell Microcap Index

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced it is set...

Jun 09, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces Nine Months Results for Fiscal Year End 2015

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced financial...

Jun 08, 2015, 17:27 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Closes $13.6 Million Registered Direct Offering

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that...

Jun 04, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical to Present at the BIO International Convention

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that CEO...

Jun 03, 2015, 09:42 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces $13.6 Million Registered Direct Offering

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it...

Jun 01, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma

 OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced a...

May 27, 2015, 13:09 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces Uplisting to The NASDAQ Stock Market LLC

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the...

May 20, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical to Present Data at the New York Academy of Sciences' Cancer Immunotherapy Symposium

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCSD), a company developing DNA-based intratumoral cancer immunotherapies, will present data from...

May 18, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical and Massachusetts General Hospital to Evaluate Efficacy of Intratumoral Delivery of DNA-Based Interleukin-12

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced it has...

May 15, 2015, 16:01 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces FINRA Approval of Reverse Stock Split

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the...

May 14, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market

OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that...

May 07, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

Robert H. Pierce, MD, Chief Scientific Officer of OncoSec Medical, Invited to Present at 11th Annual PEGS Conference in Boston

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, presented preliminary...

May 04, 2015, 06:00 ET
OncoSec Medical, Inc. Logo. Please visit http://oncosec.com/ for more information.

OncoSec Medical to Present at Prominent Scientific and Investment Conferences in May

 OncoSec Medical Inc. ("OncoSec") (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that...